Search Results

[Enfuvirtide in HIV patients: a nursing guideline for medication management].

• Authors : Bigler S; Nicca D ...

Subjects: HIV Envelope Protein gp41/HIV Envelope Protein gp41/HIV Envelope Protein gp41/*administration & dosage ; HIV Fusion Inhibitors/HIV Fusion Inhibitors/HIV Fusion Inhibitors/*administration & dosage ; HIV Infections/HIV Infections/HIV Infections/*nursing

• Source: Pflege [Pflege] 2009 Feb; Vol. 22 (1), pp. 29-38.Publisher: Hans Huber Country of Publication: Switzerland NLM ID: 8907069 Publication Model: Print Cited Medium: Print ISSN: 1012-5302 (Print)

Record details

[Pretreated HIV patients profit from Maraviroc. Oral HIV fusion inhibitor opens new therapy chances].

Subjects: Cyclohexanes/Cyclohexanes/Cyclohexanes/*therapeutic use ; HIV Fusion Inhibitors/HIV Fusion Inhibitors/HIV Fusion Inhibitors/*therapeutic use ; HIV Infections/HIV Infections/HIV Infections/*drug therapy

• Source: MMW Fortschritte der Medizin [MMW Fortschr Med] 2008 Apr 28; Vol. 150 Spec No 1, pp. 52-3.Publisher: Springer Country of Publication: Germany NLM ID: 100893959 Publication Model: Print Cited Medium: Print ISSN: 1438-3276 (Print)

Record details

[New kinds of AIDS drugs inhibit HIV entry into the cell. Entry inhibitors soon for oral administration].

• Authors : Fätkenheuer G; Klinik I für Innere Medizin--Infektio- logie, Universitäts-klinikum Köln.

Subjects: CCR5 Receptor Antagonists*; Anti-HIV Agents/Anti-HIV Agents/Anti-HIV Agents/*therapeutic use ; HIV Fusion Inhibitors/HIV Fusion Inhibitors/HIV Fusion Inhibitors/*therapeutic use

• Source: MMW Fortschritte der Medizin [MMW Fortschr Med] 2005 Apr 25; Vol. 147 Spec No 1, pp. 46-8.Publisher: Springer Country of Publication: Germany NLM ID: 100893959 Publication Model: Print Cited Medium: Print ISSN: 1438-3276 (Print)

Record details

[Fusion inhibitor enfuvirtidE. Continuous virologic and immunologic response].

• Authors : Schäfer B

Subjects: HIV Envelope Protein gp41/HIV Envelope Protein gp41/HIV Envelope Protein gp41/*therapeutic use ; HIV Fusion Inhibitors/HIV Fusion Inhibitors/HIV Fusion Inhibitors/*therapeutic use ; HIV-1/HIV-1/HIV-1/*drug effects

• Source: MMW Fortschritte der Medizin [MMW Fortschr Med] 2005 Apr 25; Vol. 147 Spec No 1, pp. 31.Publisher: Springer Country of Publication: Germany NLM ID: 100893959 Publication Model: Print Cited Medium: Print ISSN: 1438-3276 (Print)

Record details

[Fusion inhibitors. One year therapy with T-20--initial evaluation].

• Authors : Goebel FD; Med. Poliklinik, Universität München.

Subjects: HIV Envelope Protein gp41/HIV Envelope Protein gp41/HIV Envelope Protein gp41/*therapeutic use ; HIV Fusion Inhibitors/HIV Fusion Inhibitors/HIV Fusion Inhibitors/*therapeutic use ; HIV Infections/HIV Infections/HIV Infections/*drug therapy

• Source: MMW Fortschritte der Medizin [MMW Fortschr Med] 2004 Apr 26; Vol. 146 Spec No 1, pp. 42-3.Publisher: Springer Country of Publication: Germany NLM ID: 100893959 Publication Model: Print Cited Medium: Print ISSN: 1438-3276 (Print)

Record details

[Strategies for combating resistances in HIV therapy--an exemplifying case].

• Authors : Stoehr A; Institut für interdisziplinäre Infektiologie und Immunologie GmbH, Hamburg.

Subjects: Anti-HIV Agents/Anti-HIV Agents/Anti-HIV Agents/*therapeutic use ; Drug Resistance, Multiple, Viral/Drug Resistance, Multiple, Viral/Drug Resistance, Multiple, Viral/*drug effects ; HIV Envelope Protein gp41/HIV Envelope Protein gp41/HIV Envelope Protein gp41/*therapeutic use

• Source: MMW Fortschritte der Medizin [MMW Fortschr Med] 2004 Apr 26; Vol. 146 Spec No 1, pp. 70-1.Publisher: Springer Country of Publication: Germany NLM ID: 100893959 Publication Model: Print Cited Medium: Print ISSN: 1438-3276 (Print)

Record details

[Entry inhibitors. Ring-free for a new principle of action].

• Authors : Rümmelein N; KIS-Kuratorium für Immunschwäche, München.; Jäger H

Subjects: Acquired Immunodeficiency Syndrome/Acquired Immunodeficiency Syndrome/Acquired Immunodeficiency Syndrome/*drug therapy ; HIV Envelope Protein gp41/HIV Envelope Protein gp41/HIV Envelope Protein gp41/*administration & dosage ; HIV Fusion Inhibitors/HIV Fusion Inhibitors/HIV Fusion Inhibitors/*administration & dosage

• Source: MMW Fortschritte der Medizin [MMW Fortschr Med] 2003 Apr 28; Vol. 145 Spec No 1, pp. 16-20.Publisher: Springer Country of Publication: Germany NLM ID: 100893959 Publication Model: Print Cited Medium: Print ISSN: 1438-3276 (Print)

Record details

[Initial retroviral drug with new mechanism of action. Peptide T-20 enriches therapeutic arsenal].

Subjects: Anti-HIV Agents/Anti-HIV Agents/Anti-HIV Agents/*therapeutic use ; HIV Envelope Protein gp41/HIV Envelope Protein gp41/HIV Envelope Protein gp41/*therapeutic use ; HIV Fusion Inhibitors/HIV Fusion Inhibitors/HIV Fusion Inhibitors/*therapeutic use

• Source: MMW Fortschritte der Medizin [MMW Fortschr Med] 2003 Apr 28; Vol. 145 Spec No 1, pp. 55-7.Publisher: Springer Country of Publication: Germany NLM ID: 100893959 Publication Model: Print Cited Medium: Print ISSN: 1438-3276 (Print)

Record details

[Vaccines, molecular scissors, fusion inhibitors. What does HIV therapy of the future look like?].

• Authors : Warpakowski A

Subjects: Genetic Therapy*; AIDS Vaccines/AIDS Vaccines/AIDS Vaccines/*therapeutic use ; Anti-HIV Agents/Anti-HIV Agents/Anti-HIV Agents/*therapeutic use

• Source: MMW Fortschritte der Medizin [MMW Fortschr Med] 2009 Nov 12; Vol. 151 (46), pp. 22-3.Publisher: Springer Country of Publication: Germany NLM ID: 100893959 Publication Model: Print Cited Medium: Print ISSN: 1438-3276 (Print)

Record details

[HIV infection: entry and integrase inhibitors].

Subjects: HIV Fusion Inhibitors/HIV Fusion Inhibitors/HIV Fusion Inhibitors/*therapeutic use ; HIV Infections/HIV Infections/HIV Infections/*drug therapy ; HIV Integrase Inhibitors/HIV Integrase Inhibitors/HIV Integrase Inhibitors/*therapeutic use

• Source: Medizinische Monatsschrift fur Pharmazeuten [Med Monatsschr Pharm] 2007 Nov; Vol. 30 (11), pp. 393.Publisher: Wissenschaftliche Verlagsgesellschaft Country of Publication: Germany NLM ID: 7802665 Publication Model: Print Cited Medium: Print ISSN:

Record details